Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity. [electronic resource]
Producer: 20160719Description: 307-16 p. digitalISSN:- 1530-0307
- Adult
- Aged
- Aged, 80 and over
- Azacitidine -- therapeutic use
- Carrier Proteins -- physiology
- Cell Line, Tumor
- Epigenesis, Genetic
- Esophageal Neoplasms -- drug therapy
- Female
- Histone Deacetylase Inhibitors -- therapeutic use
- Humans
- Male
- Middle Aged
- Reactive Oxygen Species -- metabolism
- Thioredoxin Reductase 1 -- physiology
- Thioredoxins -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.